Search Results
Dr. Leonard Gomella on the Provenge IMPACT Trial Survival Benefit
Dr. Leonard Gomella Examines the Understating of Provenge Benefits
Dr. Gomella Discusses the Cost of the Immunotherapy Sipuleucel-T
Dr. Leonard Gomella Discusses the Benefits of a Multidisciplinary Cancer Center
Dr. Gomella Discusses New Data on Sipuleucel-T
Dr. Alter Discusses the Immunotherapy Provenge
Dr. Gomella Discusses the NeoACT Sipuleucel-T Study
Impact of Immunotherapy on the Treatment of Prostate Cancer
Dr. Leonard Gomella on the Unique Attributes of Neoadjuvant Zytiga
477 Leonard Ling, MD Provenge for Prostate Cancer, August 23, 2013
Dr. Daniel Petrylak Explains the Correlation Between Immune Response to Sipuleucel-T and Survival
Overall Survival with Sipuleucel-T in Patients Treated for Advanced Prostate Cancer
